A randomised double-blind phase II study of lifestyle counselling and salicylate compounds in patients with progressive prostate cancer

Nutrition and Food Science

Volumn 39, Issue 3, 2009, Pages 295-305

  Thomas, Robert ^a,b,c   Oakes, Roger ^d   Gordon, Julie ^a   Russell, Simon ^c   Blades, Mabel ^e   Williams, Madeleine ^a  

^a BEDFORD HOSPITAL NHS TRUST   (United Kingdom)

^b CRANFIELD UNIVERSITY   (United Kingdom)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d Ivy Medical Ltd   (United Kingdom)

^e Nutrition and Dietetic Services   (United Kingdom)

Author keywords

Cancer; Diet; Lifestyles; Patients

Indexed keywords

EID: 67651160886     PISSN: 00346659     EISSN: None     Source Type: Journal    
DOI: 10.1108/00346650910957555     Document Type: Article

References (28)

1. Cerletti, C., Bonati, M., del Maschio, A., et al. (1984), Plasma levels of salicylic acid and aspirin in healthy volunteers: relevance to drug interaction on platelet function, The Journal of Laboratory and Clinical Medicine, Vol. 103, pp. 869-77.
2. Chan, J.M., Gann, P.H. and Giovanucci, E.L. (2005), Role of diet in prostate cancer development and progression, Journal of Clinical Oncology, Vol. 23, pp. 8152-60.
3. Choo, R., Klotz, L., Deboer, G., Danjoux, C. and Morton, G.C. (2004), Wide variation of prostatespecific antigen doubling time of untreated, clinically localized, low-to-intermediate grade, prostate carcinoma, British Journal of Urology, Vol. 94, pp. 295-8.
4. Costello, A.J. (2001), A randomised controlled chemoprevention trial of selenium in familial prostate cancer: rationale, recruitment and design issues, Urology, Vol. 57, pp. 182-4.
5. Egan, K.M., Stampfer, M.J., Giovannucci, E., et al. (1996), Prospective study of regular aspirin use and the risk of breast cancer, Journal of the National Cancer Institute, Vol. 88, pp. 988-93.
6. Fuchs, C., Meyerhardt, J.A., Heseltine, D.L., et al. (2005), Influence of regular aspirin use on survival for patients with stage III colon cancer: findings from intergroup trial CALGB 89803, American Society of Clinical Oncology, Vol. 23 No. 16S, June 1 supplement, p. 3530.
7. Giovannucci, E., Rimm, E.B., Liu, Y., et al. (2002), A prospective study of tomato products, lycopene, and prostate cancer risk, Journal of the National Cancer Institute, Vol. 94, pp. 391-8.
8. Greenberg, E.R., Baron, J.A., Freeman, D.H., et al. (The Polyp Prevention Study Group) (1993), Reduced risk of large-bowel adenomas among aspirin users, Journal of the National Cancer Institute, Vol. 85, pp. 912-6.
9. Hippisley-Cox, J. and Coupland, C. (2005), Risk of myocardial infarction in patients taking cyclooxygenase inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis, British Medical Journal, Vol. 330, pp. 1366-69.
10. Hsu, A.L., Ching, T.T., Wang, D.S.D.S., et al. (2000), The cyclooxygenases-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2, Journal of Biological Chemistry, Vol. 275, pp. 11397-403.
11. Leonards, J.R. and Levy, G. (1973), Gastrointestinal blood loss from aspirin and sodium salicylate tablets in man, Clinical Pharmacology Therapeutics, Vol. 14, pp. 62-6.
12. Logan, R.F., et al. (1993), Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case control study of subjects participating in the Nottingham faecal occult blood screening programme, British Journal of Medicine, Vol. 307, pp. 285-9.
13. Li, H., Kantoff, P.W., Giovannucci, E., et al. (2005), Manganese superoxide dimutase polymorphism, prediagnostic antioxidant status and risk of clinical significant prostate cancer, Cancer Research, Vol. 65, pp. 2498-504.
14. Liu, X.H. et al. (1998), NS398, a selective cyclo-oxygenase-2 inhibitor, induces apoptosis and down regulates bcl-2 expression in lncap cells, Cancer Research, Vol. 58, pp. 4245-9.
15. Madaan, S., Adaans, S., Daan, S., et al., (2000), Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment, International Journal of Urology, Vol. 86, pp. 736-41.
16. Mahmud, S., Franco, E. and Aprikian, A. (2003), Prostate cancer and use of non-steroidal anti-inflammatory drugs: systematic Cochrane review and meta-analysis, British Journal of Cancer, Vol. 90, pp. 93-9.
17. Mestre, J.R., Mackrell, P.J., Rivadeneira, D.E., et al. (2001), Redundancy in the signaling pathways and promoter elements regulating cyclooxygenase-2 gene expression in endotoxin-treated macrophage/monocytic cells, Journal of Biological Chemistry, Vol. 276, pp. 3977-82.
18. MIMS (2003), Mims Handbook of Pain Management,
19. Omenn, G.S., Goodman, G.E., Thornquist, M.D., et al. (1996), Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene in retinol efficacy trial, Journal of the National Cancer Institute, Vol. 88, pp. 1550-9.
20. Ornish, D., Weidner, G., Fair, W.R., et al. (2005), Intensive lifestyle changes may affect the progression of prostate cancer, The Journal of Urology, Vol. 174, pp. 1065-70.
21. Pantuck, A.J., Leppert, J.T., Zomorodian, N., et al. (2006), Phase 11 study of pomegranate juice for men with rising PSA following surgery or RXT for prostate cancer, Clinical Cancer Resesearch, Vol. 12, pp. 4018-26.
22. Ravasco, R., Monteriro-Grillo, I. and Vidal, P.M. (2005), Dietary counselling improves patient outcomes: a prospective randomised trial in colorectal cancer patients undergoing radiotherapy, Journal of Clinical Oncology, Vol. 23, pp. 1431-8.
23. Sandler, R.S., Halabis, X.X.X., Baron, J.A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., et al. (2003), A randomised trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer, The New England Journal of Medicine, Vol. 348, pp. 883-90.
24. Suh, O., Mettlin, C. and Petrelli, N.J. (1993), Aspirin use, cancer and polyps of the large bowel, Cancer, Vol. 72, pp. 1171-7.
25. Thomas, R., Woodward, C. and Williams, P. (2006), Diet, salicylates and prostate cancer, British Journal of Cancer Management, Vol. 3, pp. 5-9.
26. Thomas, R., Williams, M., Blades, M. and Godward, S. (2005), Dietary advice combined with a salicylate, mineral and vitamin supplement (CV247) has some tumour static properties - a phase II study, Nutrition and science, Vol. 35, pp. 436-51.
27. Thun, M.J., Nambodiri, M.M. and Heath, C.W. (1991), Aspirin use and reduced risk of fatal colon cancer, New England Journal of Medicine, Vol. 325, pp. 1593-6.
28. Wilkinson, S. and Chodak, G.W. (2003), Critical review of complimentary therapies for prostate cancer, Journal of Clinical Oncology, Vol. 21, pp. 2199-210.